Your Comments On...

Emergent BioSolutions To Buy Maker Of Flu Vaccine

Emergent BioSolutions, in a push to diversify beyond its biodefense business, plans to announce today that it is buying Protein Sciences, a maker of a next-generation flu vaccine that federal regulators have put on a fast track to approval.
 - 

By Kendra Marr